154 related articles for article (PubMed ID: 36901698)
1. Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro.
Khosh Kish E; Gamallat Y; Choudhry M; Ghosh S; Seyedi S; Bismar TA
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901698
[TBL] [Abstract][Full Text] [Related]
2. Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro.
Choudhry M; Gamallat Y; Ghosh S; Bismar TA
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629142
[TBL] [Abstract][Full Text] [Related]
3. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
[TBL] [Abstract][Full Text] [Related]
4. Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate Cancer.
Gamallat Y; Choudhry M; Li Q; Rokne JG; Alhajj R; Abdelsalam R; Ghosh S; Arbet J; Boutros PC; Bismar TA
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345203
[TBL] [Abstract][Full Text] [Related]
5. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
[TBL] [Abstract][Full Text] [Related]
6. ARPC1B Is Associated with Lethal Prostate Cancer and Its Inhibition Decreases Cell Invasion and Migration In Vitro.
Gamallat Y; Zaaluk H; Kish EK; Abdelsalam R; Liosis K; Ghosh S; Bismar TA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163398
[TBL] [Abstract][Full Text] [Related]
7. GARS is implicated in poor survival and immune infiltration of hepatocellular carcinoma.
Wang J; Yang B; Wang D; Han R; Bi Z; Lin L
Cell Signal; 2022 Jun; 94():110302. PubMed ID: 35271987
[TBL] [Abstract][Full Text] [Related]
8. Glycyl-tRNA Synthetase Induces Psoriasis-Like Skin by Facilitating Skin Inflammation and Vascular Endothelial Cell Angiogenesis.
Zheng YX; Chen XB; Xu F; Cui YZ; Wang ZY; Zhou Y; Fu NC; Yang XY; Chen XY; Zheng M; Man XY
J Invest Dermatol; 2024 Apr; 144(4):774-785.e10. PubMed ID: 37827278
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction.
Nafisinia M; Riley LG; Gold WA; Bhattacharya K; Broderick CR; Thorburn DR; Simons C; Christodoulou J
PLoS One; 2017; 12(6):e0178125. PubMed ID: 28594869
[TBL] [Abstract][Full Text] [Related]
10. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
[TBL] [Abstract][Full Text] [Related]
11. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
[TBL] [Abstract][Full Text] [Related]
12. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
13. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation.
Oprescu SN; Chepa-Lotrea X; Takase R; Golas G; Markello TC; Adams DR; Toro C; Gropman AL; Hou YM; Malicdan MCV; Gahl WA; Tifft CJ; Antonellis A
Hum Mutat; 2017 Oct; 38(10):1412-1420. PubMed ID: 28675565
[TBL] [Abstract][Full Text] [Related]
15. Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.
Malissovas N; Griffin LB; Antonellis A; Beis D
Hum Mol Genet; 2016 Apr; 25(8):1528-42. PubMed ID: 27008886
[TBL] [Abstract][Full Text] [Related]
16. SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.
Shoag J; Liu D; Blattner M; Sboner A; Park K; Deonarine L; Robinson BD; Mosquera JM; Chen Y; Rubin MA; Barbieri CE
J Clin Invest; 2018 Jan; 128(1):381-386. PubMed ID: 29202479
[TBL] [Abstract][Full Text] [Related]
17. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Lehrer S; Rheinstein PH
Am J Clin Oncol; 2020 Oct; 43(10):685-689. PubMed ID: 32568785
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of glycyl-tRNA synthetase (GARS) gene in Hirayama disease.
Blumen SC; Drory VE; Sadeh M; El-Ad B; Soimu U; Groozman GB; Bouchard JP; Goldfarb LG
Amyotroph Lateral Scler; 2010; 11(1-2):237-9. PubMed ID: 19412816
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
Dai X; Gan W; Li X; Wang S; Zhang W; Huang L; Liu S; Zhong Q; Guo J; Zhang J; Chen T; Shimizu K; Beca F; Blattner M; Vasudevan D; Buckley DL; Qi J; Buser L; Liu P; Inuzuka H; Beck AH; Wang L; Wild PJ; Garraway LA; Rubin MA; Barbieri CE; Wong KK; Muthuswamy SK; Huang J; Chen Y; Bradner JE; Wei W
Nat Med; 2017 Sep; 23(9):1063-1071. PubMed ID: 28805820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
